| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.01B | +16.7% |
| Cost of Revenue | $5.08B | +13.8% |
| R&D Expense | $352.1M | +16.0% |
| SG&A Expense | $1.37B | +4.7% |
| Operating Income | $1.37B | +56.8% |
| Interest Expense | $150.4M | -16.5% |
| Pre-tax Income | $765.4M | +43.4% |
| Income Tax | $269.6M | +266.8% |
| Net Income | $495.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.23B | +57.3% |
| Accounts Receivable | $2.36B | +8.1% |
| Inventory | $1.24B | +40.7% |
| Current Assets | $5.10B | +27.5% |
| Total Assets | $9.13B | +14.2% |
| Current Liabilities | $3.10B | +34.3% |
| Long-term Debt | $2.93B | -0.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.32B | +46.5% |
| Capital Expenditures | $167.0M | +30.6% |
| Investing Cash Flow | -$201.7M | -45.0% |
| Financing Cash Flow | -$652.1M | -163.5% |
| Free Cash Flow | $1.15B | +49.1% |
| +7.7% |
| EPS (Basic) | $1.32 | +9.1% |
| EPS (Diluted) | $1.28 | +7.6% |
| Total Liabilities |
| $6.70B |
| +11.9% |
| Stockholders' Equity | $2.43B | +20.8% |